Concepedia

Hadija Semvua

HS

17

Publications

963

Citations

14

H-Index

2009

Active since

Affiliations

Radboud University Nijmegen(Current)

Radboud University Medical Center

Kilimanjaro Christian Medical Centre

University of St Andrews

Ludwig-Maximilians-Universität München

Hadija Semvua is an author at Radboud University Nijmegen specializing in health informatics, tuberculosis, and telehealth.

ORCID

Top concepts

Publications per year

2009–2025

17

Publications

17

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

Martin J. Boeree, Norbert Heinrich, Rob E. Aarnoutse et al. · The Lancet Infectious Diseases · 2016 · 379 citations · Full text

Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients

Norbert Heinrich, Rodney Dawson, Jeannine du Bois et al. · Journal of Antimicrobial Chemotherapy · 2015 · 91 citations · Full text

Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis

R.E. Aarnoutse, Gibson Kibiki, Klaus Reither et al. · Antimicrobial Agents and Chemotherapy · 2017 · 89 citations · Full text

Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian Patients

Alma Tostmann, Charles Mtabho, Hadija Semvua et al. · Antimicrobial Agents and Chemotherapy · 2013 · 66 citations · Full text

Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy

Mohamed I. M. Ahmed, Nyanda Elias Ntinginya, Gibson Kibiki et al. · Frontiers in Immunology · 2018 · 59 citations · Full text

Rows per page

1–5 of 17